|
EGFR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.396000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.960600E-01 |
| Normal-vs-Stage2 |
6.605400E-01 |
| Normal-vs-Stage3 |
4.968600E-01 |
| Normal-vs-Stage4 |
8.617000E-01 |
| Stage1-vs-Stage2 |
9.997400E-01 |
| Stage1-vs-Stage3 |
3.070400E-01 |
| Stage1-vs-Stage4 |
9.374400E-01 |
| Stage2-vs-Stage3 |
4.114600E-01 |
| Stage2-vs-Stage4 |
9.325000E-01 |
| Stage3-vs-Stage4 |
5.928600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.718000E-01 |
| Normal-vs-AfricanAmerican |
6.947200E-01 |
| Normal-vs-Asian |
6.502000E-01 |
| Caucasian-vs-AfricanAmerican |
6.919600E-01 |
| Caucasian-vs-Asian |
7.282600E-01 |
| AfricanAmerican-vs-Asian |
8.247800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.812220E-01 |
| Normal-vs-Female |
4.333700E-02 |
| Male-vs-Female |
6.041800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.784200E-01 |
| Normal-vs-Extreme_Weight |
1.462780E-01 |
| Normal-vs-Obese |
4.611800E-01 |
| Normal-vs-Extreme_Obese |
1.897830E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.791600E-01 |
| Normal_Weight-vs-Obese |
3.786200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.562000E-01 |
| Extreme_Weight-vs-Obese |
7.637800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.937200E-01 |
| Obese-vs-Extreme_Obese |
2.420200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.315600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.591400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.229700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.539000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.876200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.170770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.055050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.217670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.224800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.189800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.499000E-01 |
| Normal-VS-Type2 PRCC |
7.148200E-01 |
| Normal-VS-KIRP CIMP |
3.130100E-02 |
| Normal-VS-Unclassified PRCC |
8.774300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.743600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.214300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.820400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.657900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.135900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.372100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.652980E-01 |
| Normal-vs-N1 |
1.492030E-01 |
| Normal-vs-N2 |
4.486600E-01 |
| N0-vs-N1 |
5.037600E-02 |
| N0-vs-N2 |
9.767400E-01 |
| N1-vs-N2 |
4.014600E-01 |
|
|
